Attached files

file filename
EX-99.1 - PRESS RELEASE - CERADYNE INCex99-1.htm





 
UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C.  20549
 

FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported)
 
July 19, 2010
 

(Exact name of registrant as specified in its charter)
Delaware
 
000-13059
 
33-0055414
(State or other Jurisdiction of Incorporation)
 
(Commission File Number)
 
(IRS Employer Identification No.)

     
3169 Red Hill Avenue, Costa Mesa, CA
 
92626
(Address of Principal Executive Offices)
 
(Zip Code)
 
Registrant's telephone number, including area code:  (714) 549-0421
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Exhibit Index on page 4
 

 
 

 


 
Item 7.01  Regulation FD Disclosure.
 
On July 19, 2010, Ceradyne Boron Products, LLC (“Boron Products, LLC”), a wholly owned subsidiary of Ceradyne, Inc., announced a contract award of approximately $8 million for the supply of B-10 Enriched Boric Acid to Electricité de France SA (EDF) for its first European Pressurized Reactor (EPR) presently under construction in France. A copy of this press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K.
 
In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933.
 

Item 9.01 Financial Statements and Exhibits.


(d)
Exhibits.
 
 
 
Exhibit Number
Description
 
 
99.1
 
Press release of Ceradyne, Inc. dated July 19, 2010.
 
 
 
 

 

 
2

 


 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 

 
 
CERADYNE, INC.
 
 
July 20, 2010
By:
/s/ Jerrold J. Pellizzon
   
Jerrold J. Pellizzon
   
Chief Financial Officer and Secretary


 

 
 

 

 
3

 


 
EXHIBIT INDEX
 
Exhibit Number
Description
 
99.1
 
Press release of Ceradyne, Inc. dated July 19, 2010.
 
 
 
 

 
 
4